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Age-related oxidative stress is generated by a combination 
of increased production of free radicals, decreased 
antioxidants levels, diminished activity  of antioxidant 
enzymes and impaired repair of oxidative damages. 
Oxidative stress is associated with many diseases 
commonly present in elderly such as hypertension and 
diabetes. In our study we have observed significantly 
(p<0,01) increased level of reduced glutathione in treated 
hypertensive compared to treated diabetic patients (3,1± 
0,29 mmol/L  and 2,72 ± 0,4 mmol/L, respectively) and 
significantly (p<0,01) increased activity of glutathione 




The oxidative hypothesis of senescence has 
been introduced in 1956 by Harman and 
has become one of the most prolific theories 
of aging  since its origin [1,2]. This age-
related oxidative stress is generated by  
a combination of increased production of 
free radicals, decreased antioxidants levels, 
diminished activity  of antioxidant enzymes 
and impaired repair of oxidative damages. 
There are many physiological processes in 
the  human body which generate  reactive 
oxygen species (ROS) which due to their 
unstability and high reactivity are harmful 
for the cells. To protect themselves from 
ROS, cells are equipped with antioxidant 
enzymes i.e. superoxide dismutase (SOD) 
catalyzes dismutation of O2•-, catalase 
(CAT) scavenges H2O2, glutathione 
peroxidase (GPx) converts H2O2 to water 
and neutralizes lipid peroxyl radials. 
Glutathione serves as a major thiol-
disulfide redox buffer of the cell and its 
reduced form pool is maintained by 
glutathione reductase (GR). When oxidants 
are produced in excess and overwhelm the 
cellular antioxidant capacity the state of 
oxidative stress occurs. This can result in 
molecular and cellular tissue damage as 
well as in severe metabolic malfunctions 
caused by oxygen radical-mediated toxicity 
[3].  It has been established taht O2•-, H2O2 
and ONOO- which is formed in radical-
radical coupling reactions, play an 
important role in the development of 
hypertension due to their effect on vascular 
tone [4] and the major source of vascular 
ROS production are NADP(H) oxidases, [5]. 
Furthermore decreased endogenous 
antioxidant status has been observed in 
essential hypertension [6]. Likewise,  
imbalance between oxidants and 
antioxidants has been reported in diabetes 
mellitus [7] and reactive oxygen metabolites 
increase the autooxidation of glucose and 
glycosylated proteins as well as activate 
polyol pathways [8]. Altogether previous 
results of oxidative stress parameters and 
antioxidant enzymes activity are divergent 
and so far we are not able to state explicitly 
how they change in particular health 
condition, therefore further studies are 
required.   The aim of this study was to 
compare concentration of reduced 
glutathione and activity of glutathione 
reductase and glutathione peroxidase in 
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2. Materials and methods 
 
30 elderly patients age above 60 were 
recruited to the Department of Gerontology 
and Clinic of Geriatrics, Nicolaus 
Copernicus University Collegium Medicum 
in Bydgoszcz, Poland. There were 12 and 18 
patients with type II diabetes and essential 
hypertension, respectively. Exclusion 
criteria for both experimental groups were 
cardiovascular diseases, cancer, dementia, 
Alzheimer disease, antioxidants 
supplementation, smoking and alcohol 
abuse. We distinguished HT group for 
hypertensive patients  currently treated for  
and DM with no hypertension neither 
presently nor in medical record. 
Hypertensive  as well as diabetic patients 
were treated for their condition. Groups 
were age and sex matched. 
The study was approved by the Nicolaus 
Copernicus University  in Toruń Human 
Ethics Committee. Written informed 
consent was obtained before inclusion in 
the study.  
Venous EDTA anti-coagulated blood 
samples were taken from the cubital vein. 
GSH concentration was determined in 
whole blood (method described by Beutler, 
1971), GPx1 and GR activities were 
determined in erythrocytes from hemolysed 
blood samples  acording to Paglia & 
Valentine, 1967;  Flohe & Gunzler  methods, 
respectively. We performed statistical 
analyses with Statistica version 9 software 
for the comparisons between measured 
parameters in experimental groups. P-
values of less than  0.05 were considered to 
indicate statistical significance in 




The antioxidant barrier defined as 
antioxidant enzymes activity and 
concentration of antioxidants in treated 
elderly patients with diabetes mellitus type 
two has been demonstrated to function 
unlike in hypertensive patients. First, in 
order to analyse whether oxidative stress 
parameters varied between groups we have 
measured GSH concentration. The mean 
GSH concentration (mmol/L) was 
significantly lower in DM group compared 
to HT group (p<0,01) with values of  2,7 ± 
0,38 mmol/L and 3,1± 0,29 mmol/L, 
respectively (Fig.1). Lower concentration of 
GSH in DM group when compared to HT 
group, was accompanied by decreased 
activity of GR (Fig. 2). Mean enzyme 
activity was significantly lower in diabetics 
(p<0,01) than in hypertensives. GR 
exhibited activities of 63,8 ± 15,15 U/g Hb 
and 83,4± 15,25 U/g Hb in DM and HT 
groups, respectively. We have also 
measured GPx activity, however no 
significant differences between analysed 
groups were discovered in this case. 
Activity of GPx1 was as high as 12,76 ± 2,65 
U/g Hb and 13,16 ± 1,95 U/g Hb in patients 
treated for diabetes and for hypertension, 
respectively which again follows the 
pattern of decreased antioxidants in 
diabetes mellitus type II patients in 
comparison to hypertensive patients in our 
study. 
Altogether this results suggest that diabetes 
mellitus type II and essential hypertension 
which both has been proven to be 
associated with oxidative stress may differ 
regarding to mechanisms implicating 
oxidative stress in their pathogenesis as 
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Fig. 1. Mean GSH concentration in elderly patients with type II diabetes compared to



























































Results from this research suggest 
significantly decreased level of glutathione 
(GSH) in treated diabetes type II elderly 
subjects when compared with these treated 
for hypertension. Majority of studies  reveal 
decrease of GSH in pathological conditions 
analysed [9,10] but we can not conclude it 
from the data presented  herein still we 
have not compared the result of patients 
from our groups with healthy controls at 
the same age. However we have done 
similar study before and interestingly when 
parallelly analyzed the same parameters in 
controls we observed that patients with 
treated hypertension had significantly 
higher GSH concentration than subjects 
from two other groups which have had 
similar level of GSH. The explanation of this 
phenomenon may be that antioxidant thiols 
concentration increase due to higher 
concentration of ROS which means that 
hypertensives are more volnurable to 
oxidative stress. Glutathione deficiency 
contributes to oxidative stress, which plays 
important role in aging and the 
pathogenesis of many diseases such as 
diabetes and cardiovascular diseases [11, 
12]. On the other hand higher level of 
reduced glutathione can be considered as 
better protection against oxidative stress 
since protective role of glutathione against 
oxidative stress among other important 
functions has been recognized [13].  
 In order to better understand the 
mechanisms of  GSH increase in 
hypertension the values of other parameters 
of oxidative stress and antioxidant defense 
need to be taken into account as well as the 
fact that important confounder in our study 
was the medication. Antihypertensive 
drugs are indeed proven to have 
antioxidant properties [14, 15, 16, 17, 18]. 
Since hypertensive patients received 
different antihypertensive drugs with 
various combinations in this group we 
could look for the complete status of 
antihypertensive drugs effect over oxidative 
stress alone. 
The relation between oxidative stress 
and blood pressure is explained through 
inactivation of the vasodilator nitric oxide 
(NO)  by ROS and formation of 
peroxynitrite ONOO [15]. GSH plays 
important role in maintenance of NO pool. 
GSH reacts with peroxynitrite to produce S-
nitrosoglutathione (GSNO) which extends 
the half-life of NO and in consequence 
contributes in relaxation of vascular tissue 
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[20]. GSH enhances decomposition of 
nitrosothiols and release of NO [21]. 
Moreover nitrosothiols have the ability to 
inhibit NADPH oxidase and therefore have 
beneficial effect on vascular tension. Other 
important role of GSH is control of PDGF-
mediated ROS production by 
NADH/NADPH oxidase which is 
considered to be the main source of 
vascular ROS [5, 15, 22].  
Well-established role of GSH is reduction of 
hydrogen peroxide in the presence of GPx 
Reduced form of glutathione is restored by 
glutathione reductase  (GR) [13]. In our 
study GPx1 activity has not differed 
significantly while comparing two 
examined groups. Results of other studies 
concerning GPx activity in HT subjects are 
contradictory showing both increased and 
decreased activity of the enzyme [23]. The 
same conclusion can be made regarding 
review of diabetes mellitus studies [ 24, 25]. 
Although GPx1 remained unchanged, GR 
activity increased significantly in HT group. 
This observation  has been interrelated with 
GSH concentration analyses. We assumed 
that elevated level of glutathione is the 
result of increased activity of GR. However, 
this parameters are not significantly 
correlated in our study.  
Protective role of GPx1 in coping with 
oxidative injury and cell death mediated by 
reactive oxygen species in vivo has been 
supported by substantial body of evidence. 
Among other important functions in coping 
with oxidative stress GPx possesses the 
ability to decompose GSNO and is also 
responsible for lipid hydroperoxides 
reduction, thereby preventing inactivation 
of NO [26]. 
Nevertheless the ability to potentiate 
reactive nitrogen species stress has been 
also reported. GPx seems to play 
contradictory roles in coping with ROS vs. 
RNS [27].  
Altogether our results suggest that the 
mechanisms which link oxidative stress 
with various pathological conditions may 
differ and may be associated with changes 
of different parameters depending of the 
pathogenesis of the condition and 
furthermore the action of pharmaceutical 
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